All Updates

All Updates

icon
Filter
Funding
MapLight Therapeutics raises USD 225 million in Series C funding for Phase 2 trials of novel therapeutic candidate ML-007C-MA
Precision Medicine
Oct 29, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Precision Medicine

Precision Medicine

Oct 29, 2023

MapLight Therapeutics raises USD 225 million in Series C funding for Phase 2 trials of novel therapeutic candidate ML-007C-MA

Funding

  • MapLight Therapeutics raised  USD 225 million in a Series C funding round led by Novo Holdings, with participation from new investors, including 5AM Ventures and Cowen Healthcare Investments. This brings the company's total funding to USD to USD 268.1 million.

  • The funds are expected to be used for the development of ML-007C-MA, MapLight's novel therapeutic candidate, into Phase 2 trials for schizophrenia and Alzheimer's disease psychosis, set for 2024, and to bolster the company's other pipeline programs.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.